News

August 24, 2018 10:30 am
August 23, 2018 12:00 pm
The FDA has granted a priority review to a supplemental biologics license application (sBLA) for Empliciti (elotuzumab) for use in combination with Pomalyst (pomalidomide) and low-dose dexamethasone (EPd) for the treatment of patients with relapsed/...
August 20, 2018 12:00 pm
To celebrate the last month of summer, from August 18th to September 20th, Triage Cancer will be auctioning off fun and unique items to support their educational programs and services that support the cancer community. Anyone can participate, so...

Pages